New Science Ventures
Funding rounds backed by New Science Ventures.
- Funding disclosed in full
- $9M
- Median round
- $9M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Trellis Bioscience Developing native human monoclonal antibodies to treat intractable infectious diseases | $9MSeries C | BiotechUnited States |